Letizia C, Minisola S, Cerci S, Tarsitani P, De Ciocchis A, Scavo D
Istituto di II Clinica Medica, Università degli Studi di Roma La Sapienza.
Minerva Endocrinol. 1992 Jul-Sep;17(3):103-6.
This study was carried out in order to investigate serum changes of osteocalcin (BGP) and angiotensin converting enzyme (SACE) activity in a group of patients with hyperthyroidism. We studied 20 hyperthyroid patients (F 14, M 6; age mean 37.5 +/- 16.8 years) and 13 control subjects (F 11, M 2; age mean 40.3 +/- 7.5 years). In both patients and controls we measured: FT3, FT4, T3, T4, TSH, BGP, SACE. Finally, in patients with hyperthyroidism a TRH test and functional investigations were also performed. We observed that mean SACE levels were significantly increased in hyperthyroid patients (32.06 +/- 10.3 nmol/ml/min) in respect to control subjects (14.66 +/- 3.88 nmol/ml/min) (p = 2.02 E-6). Similarly serum BGP levels were significantly increased in hyperthyroid patients (5.94 +/- 2.55 ng/ml) than in control subjects (2.89 +/- 1.58 ng/ml) (p = 5.66 E-4). There was a significant linear correlation between SACE and T4 levels (r = 0.48; p < 0.05), between serum BGP and T4 (r = 0.50; p < 0.02) and furthermore between SACE and BGP (r = 0.57; p < 0.01). In conclusion both serum BGP and SACE levels are increased in patients with hyperthyroidism and are directly correlated between than and with indexes of thyroid function; therefore, they may be regarded as peripheral indexes of hyperthyroidism.
本研究旨在调查一组甲状腺功能亢进患者血清骨钙素(BGP)和血管紧张素转换酶(SACE)活性的变化。我们研究了20例甲状腺功能亢进患者(女性14例,男性6例;平均年龄37.5±16.8岁)和13例对照者(女性11例,男性2例;平均年龄40.3±7.5岁)。在患者和对照者中,我们均测量了:游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、总三碘甲状腺原氨酸(T3)、总甲状腺素(T4)、促甲状腺激素(TSH)、BGP、SACE。最后,对甲状腺功能亢进患者还进行了促甲状腺激素释放激素(TRH)试验和功能检查。我们观察到,与对照者(14.66±3.88nmol/ml/min)相比,甲状腺功能亢进患者的平均SACE水平显著升高(32.06±10.3nmol/ml/min)(p = 2.02×10⁻⁶)。同样,甲状腺功能亢进患者的血清BGP水平(5.94±2.55ng/ml)显著高于对照者(2.89±1.58ng/ml)(p = 5.66×10⁻⁴)。SACE与T4水平之间存在显著的线性相关性(r = 0.48;p < 0.05),血清BGP与T4之间存在显著的线性相关性(r = 0.50;p < 0.02),此外,SACE与BGP之间也存在显著的线性相关性(r = 0.57;p < 0.01)。总之,甲状腺功能亢进患者的血清BGP和SACE水平均升高,且二者之间以及它们与甲状腺功能指标之间直接相关;因此,它们可被视为甲状腺功能亢进的外周指标。